Get startedLog in
    Picture of WuXi Biologics (Cayman) logo

    2269 — WuXi Biologics (Cayman) News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeLarge CapHigh Flyer
    All News

    Brief: Candid Therapeutics Enters Into Agreement With Wuxi Biologics On Trispecific T-Cell Engager

    Picture of WuXi Biologics (Cayman) logoWuXi Biologics (Cayman)
    07/01/2025 24:02
    Jan 6 (Reuters) - 
  
    * CANDID THERAPEUTICS ENTERS INTO AGREEMENT WITH WUXI
BIOLOGICS ON
TRISPECIFIC T-CELL ENGAGER
    * CANDID THERAPEUTICS - WUXI BIOLOGICS TO RECEIVE UP TO $925
MILLION IN PAYMENTS AND MILESTONES
    * CANDID - PLANS TO COMPLETE IND ENABLING STUDIES TO ENABLE
FIRST-IN-HUMAN STUDIES IN FIRST HALF OF 2026

Source text:  ID:nBw7pY2dZa 
Further company coverage:  2269.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on WuXi Biologics (Cayman)

    See all news